APA (7th ed.) Citation

Feillet, F., Ficicioglu, C., Lagler, F. B., Longo, N., Muntau, A. C., Burlina, A., . . . Burton, B. K. (2024). Efficacy and safety of sapropterin before and during pregnancy: Final analysis of the Kuvan® Adult Maternal Paediatric European Registry (KAMPER) maternal and Phenylketonuria Developmental Outcomes and Safety (PKUDOS) PKU-MOMs sub-registries. Journal of inherited metabolic disease, 47(4), . https://doi.org/10.1002/jimd.12724

Chicago Style (17th ed.) Citation

Feillet, François, et al. "Efficacy and Safety of Sapropterin Before and During Pregnancy: Final Analysis of the Kuvan® Adult Maternal Paediatric European Registry (KAMPER) Maternal and Phenylketonuria Developmental Outcomes and Safety (PKUDOS) PKU-MOMs Sub-registries." Journal of Inherited Metabolic Disease 47, no. 4 (2024). https://doi.org/10.1002/jimd.12724.

MLA (9th ed.) Citation

Feillet, François, et al. "Efficacy and Safety of Sapropterin Before and During Pregnancy: Final Analysis of the Kuvan® Adult Maternal Paediatric European Registry (KAMPER) Maternal and Phenylketonuria Developmental Outcomes and Safety (PKUDOS) PKU-MOMs Sub-registries." Journal of Inherited Metabolic Disease, vol. 47, no. 4, 2024, https://doi.org/10.1002/jimd.12724.